MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM

Glioblastoma is the most aggressive brain tumor in adults with a median survival below 12 months in population-based studies. The main reason for tumor recurrence and progression is constitutive or acquired resistance to the standard of care of surgical resection followed by radiotherapy with concom...

Descripción completa

Detalles Bibliográficos
Autores principales: Stojcheva, Nina, Schechtmann, Gennadi, Sass, Steffen, Roth, Patrick, Florea, Ana-Maria, Stefanski, Anja, Stühler, Kai, Wolter, Marietta, Müller, Nikola S., Theis, Fabian J., Weller, Michael, Reifenberger, Guido, Happold, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914333/
https://www.ncbi.nlm.nih.gov/pubmed/26887050
http://dx.doi.org/10.18632/oncotarget.7346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914333/
https://www.ncbi.nlm.nih.gov/pubmed/26887050
http://dx.doi.org/10.18632/oncotarget.7346

Ejemplares similares